Skip to main content

ADVERTISEMENT

Nagesh Kalakonda, MD

Nagesh Kalakonda, MD
Videos
07/11/2023
Nagesh Kalakonda, MD, discusses final results from the L-MIND study, in which the combination of tafasitamab plus lenalidomide demonstrated durable responses and curative potential for patients with R/R DLBCL.
Nagesh Kalakonda, MD, discusses final results from the L-MIND study, in which the combination of tafasitamab plus lenalidomide demonstrated durable responses and curative potential for patients with R/R DLBCL.
Nagesh Kalakonda, MD, discusses...
07/11/2023
Oncology